Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Protocol ID
ONC201-108
Disease (Sub Disease)
Diffuse Glioma
Diagnosis Stage
Newly diagnosed
Location
NSW
Sponsor
Chimerix
Trial Status
Open
Sites
Sydney Children's Hospital
Study Type
Treatment
Phase
Phase 3
Age Eligibility
Child, Adult, Older Adult
International registry ID's
NCT05580562
Back to Registry
Study Title ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized Double-Blind Placebo-Controlled Multicenter Study
Protocol ID ONC201-108
Disease (Sub Disease) Diffuse Glioma
Diagnosis Stage Newly diagnosed
Location NSW
Sponsor Chimerix
Links https://clinicaltrials.gov/study/NCT05580562
Trial Status Open
Sites Sydney Children's Hospital
Study Type Treatment
Phase Phase 3
Age Eligibility Child, Adult, Older Adult
International registry ID's NCT05580562